Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
rocilinostat (ACY-1215)
print preview
bookmark
share with colleague
General Information
Company
Acetylon Pharmaceuticals Inc.
Description
Oral selective histone deacetylase 6 (HDAC6) inhibitor
Molecular Target
Histone deacetylase 6 (HDAC6)
Mechanism of Action
Latest Stage of Development
Phase I/II
Indication
Multiple myeloma (MM)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information